Novel medical indication of Baclofen and other GABAB receptor specific agonists
Scientists from the university hospital of Frankfurt am Main found that baclofen significantly improves the medical therapy in a so far unknown field of medical application. Furthermore, the results implicate that other GABAB receptor specific agonists hold a comparative potential. The new indication applies to a multitude of patients mainly in industrialised countries. According to the physicians this means an important enhancement of today?s possibilities of treatment for these patients.
Further Information: PDF
INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/798-49721
Contact
Dr. Otmar Schöller
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Microscopic basis of a new form of quantum magnetism
Not all magnets are the same. When we think of magnetism, we often think of magnets that stick to a refrigerator’s door. For these types of magnets, the electronic interactions…
An epigenome editing toolkit to dissect the mechanisms of gene regulation
A study from the Hackett group at EMBL Rome led to the development of a powerful epigenetic editing technology, which unlocks the ability to precisely program chromatin modifications. Understanding how…
NASA selects UF mission to better track the Earth’s water and ice
NASA has selected a team of University of Florida aerospace engineers to pursue a groundbreaking $12 million mission aimed at improving the way we track changes in Earth’s structures, such…
